V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 260009791 | 260006251 | 1.84 | 75 | Disease modification (D) | 2016-01-25 | 2016-02-01 | CISPLATIN + IFOSFAMIDE + VINBLASTINE | N | N | 260010109 | CARBOPLATIN + ETOPOSIDE |
| 260009792 | 260006252 | null | 76.4 | Neo-adjuvant (N) | 2017-01-18 | 2017-02-21 | BLEOMYCIN + CARBOPLATIN + CISPLATIN + VINCRISTINE | 02 | N | 260010121 | CISPLATIN + ETOPOSIDE |
| 260009793 | 260006252 | 1.63 | 53 | Curative (C) | 2017-09-14 | 2017-09-22 | Rituximab | 02 | N | 260010121 | RITUXIMAB |
| 260009794 | 260006253 | 1.7 | 79 | Curative (C) | 2014-05-02 | 2014-05-02 | Trial Unspecified | 02 | null | 260010146 | EP |
| 260009795 | 260012377 | 1.76 | 68 | Curative (C) | null | 2016-05-28 | CISPLATIN + FLUOROURACIL + RT | N | n | 260010151 | BENDAMUSTINE |
| 260009796 | 260006254 | null | 58.6 | Adjuvant (A) | 2014-08-27 | 2014-09-27 | Rituximab | N | N | 260010160 | RITUXIMAB |
| 260009797 | 260006254 | 1.7 | 68.8 | Curative (C) | 2013-05-27 | 2013-06-30 | TIP | 2 | N | 260010160 | EP |
| 260009798 | 260006255 | 1.6 | 53.2 | Curative (C) | null | 2016-10-10 | GEMCARBO | null | null | 260010175 | CHOP |
| 260009799 | 260012379 | 1.79 | null | Disease modification (D) | 2018-02-23 | 2018-03-10 | Rituximab | 2 | null | 260010183 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260009800 | 260006256 | 1.77 | null | Adjuvant (A) | 2018-11-18 | 2018-12-14 | Cisplatin + Etoposide (3 day) | N | Y | 260010191 | ETOPOSIDE |
| 260009801 | 260006256 | 1.71 | 114 | Not known (9) | 2015-12-03 | 2015-12-03 | Bendamustine +/- Prednisolone | 02 | null | 260010191 | DOXORUBICIN + IFOSFAMIDE |
| 260009802 | 260006257 | 1.6 | 67.4 | Disease modification (D) | 2015-09-02 | 2015-09-12 | Rituximab | 02 | N | 260010207 | RITUXIMAB |
| 260009803 | 260006258 | 1.6 | 69 | Curative (C) | 2016-01-05 | 2016-01-05 | R Chlorambucil | 2 | N | 260010212 | RITUXIMAB |
| 260009804 | 260006259 | 1.66 | 119.9 | Curative (C) | 2014-06-23 | 2014-06-29 | Rituximab | N | N | 260010213 | RITUXIMAB |
| 260009805 | 260006260 | 1.8 | 92 | null | 2016-11-20 | 2016-12-11 | Carboplatin + Etoposide IV 3 day | N | N | 260010220 | CISPLATIN + ETOPOSIDE |
| 260009806 | 260006260 | 1.85 | 64.3 | Disease modification (D) | 2013-06-18 | 2013-06-24 | Irinotecan + Modified De Gramont | N | N | 260010220 | RITUXIMAB |
| 260009807 | 260006261 | 1.81 | 95 | null | 2018-05-08 | 2018-05-12 | ECX | 02 | null | 260010238 | CISPLATIN + ETOPOSIDE |
| 260009808 | 260012382 | null | 76.7 | Adjuvant (A) | 2017-02-14 | 2017-02-20 | Cisplatin + Etoposide (5 day) | 02 | N | 260010275 | NOT MATCHED |
| 260009809 | 260006262 | null | 114.3 | Disease modification (D) | 2015-09-03 | 2015-09-06 | Cisplatin + Etoposide po&iv 3 day | N | N | 260010297 | EP |
| 260009810 | 260006262 | null | null | Palliative (P) | 2016-10-06 | 2016-10-29 | 111 Trial (formerly BEP 111) | N | N | 260010297 | PEMBROLIZUMAB |
| 260009811 | 260006263 | 1.63 | null | Palliative (P) | null | 2016-02-28 | EP | N | N | 260010334 | EP |
| 260009812 | 260012384 | 1.87 | 94 | Curative (C) | 2018-06-24 | 2018-07-18 | Cisplatin + Etoposide (5 day) | 02 | N | 260010335 | CARBOPLATIN + ETOPOSIDE |
| 260009813 | 260006264 | null | 77.6 | Palliative (P) | null | 2017-01-13 | Rituximab | null | null | 260010341 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260009814 | 260006264 | 1.9 | 74.3 | Palliative (P) | 2015-10-22 | 2015-12-28 | EP | Y | N | 260010341 | EP |
| 260009815 | 260006265 | 1.76 | 121 | null | 2014-08-20 | 2014-08-21 | Cisplatin + Etoposide (3 day) | N | null | 260010361 | EP |
| 260009816 | 260006266 | 1.76 | null | Curative (C) | 2018-08-19 | 2018-08-24 | CISPLATIN + ETOPOSIDE | N | N | 260010386 | CISPLATIN + ETOPOSIDE |
| 260009817 | 260012386 | 1.76 | 55.7 | Palliative (P) | 2014-03-30 | 2014-03-30 | Cisplatin + Etoposide (5 day) | N | N | 260010400 | CISPLATIN + ETOPOSIDE |
| 260009818 | 260006267 | 1.72 | 72 | Adjuvant (A) | 2014-08-19 | 2014-08-26 | CHLORAMBUCIL + OBINUTUZUMAB | N | N | 260010401 | SUNITINIB |
| 260009819 | 260006267 | 1.6 | 84 | null | null | 2015-12-12 | CISPLATIN + RT | null | null | 260010401 | RITUXIMAB |
| 260009820 | 260006268 | 0 | 61.2 | Palliative (P) | 2019-05-18 | 2019-05-20 | CARBOPLATIN + VINORELBINE | 02 | N | 260010415 | RITUXIMAB |
| 260009821 | 260006269 | 1.49 | 67.2 | Curative (C) | 2017-09-23 | 2017-09-23 | Bendamustine + prednisolone | N | N | 260010422 | RITUXIMAB |
| 260009822 | 260006269 | 1.67 | 119.6 | Curative (C) | 2015-03-26 | 2015-04-19 | Cisplatin + Etoposide (3 day) | N | N | 260010422 | CARBOPLATIN + ETOPOSIDE |
| 260009823 | 260006270 | null | null | Curative (C) | 2014-05-02 | 2014-06-06 | Rituximab | null | null | 260010437 | BENDAMUSTINE |
| 260009824 | 260006270 | 1.76 | 82 | Curative (C) | 2018-01-18 | 2018-02-03 | ACE (germ cell) | N | N | 260010437 | CISPLATIN + ETOPOSIDE |
| 260009825 | 260006270 | 1.72 | 67.2 | Radical (R) | null | 2015-06-01 | CISPLATIN + ETOPOSIDE | N | N | 260010437 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009826 | 260006271 | null | null | null | 2016-12-22 | 2017-01-07 | ACE (germ cell) | 2 | N | 260010470 | TIP |
| 260009827 | 260006271 | null | 80.3 | Curative (C) | 2013-04-05 | 2013-05-16 | EP | 2 | Y | 260010470 | BLEOMYCIN + CISPLATIN + VINCRISTINE |
| 260009828 | 260006271 | 1.69 | 104 | Curative (C) | 2017-09-19 | 2017-09-20 | R Chlorambucil | 02 | null | 260010470 | CISPLATIN + ETOPOSIDE |
| 260009829 | 260006271 | 1.6 | 69 | Disease modification (D) | 2016-05-17 | 2016-05-27 | CISPLATIN + GEMCITABINE + RITUXIMAB | 2 | N | 260010470 | PACLITAXEL |
| 260009830 | 260017474 | 1.8 | 99 | Palliative (P) | null | 2016-09-29 | Rituximab (Maintenance) | N | N | 260010512 | CISPLATIN + ETOPOSIDE |
| 260009831 | 260006272 | 1.81 | 75.7 | Curative (C) | 2016-02-07 | 2016-02-14 | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 2 | N | 260010514 | CISPLATIN + ETOPOSIDE |
| 260009832 | 260012391 | 1.49 | 64 | null | null | 2015-11-06 | Rituximab (SUBCUTANEOUS Maintenance) | null | null | 260010535 | CISPLATIN |
| 260009833 | 260012391 | null | 73.6 | Adjuvant (A) | 2016-11-30 | 2016-11-30 | Rituximab | 02 | N | 260010535 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 260009834 | 260012391 | 1.68 | null | Disease modification (D) | 2017-03-18 | 2017-03-22 | PMitCEBO | N | N | 260010535 | CYCLO + RITUXIMAB + VINCRISTINE |
| 260009835 | 260006273 | null | 69.2 | Disease modification (D) | 2016-03-28 | 2016-03-30 | Cisplatin + Etoposide (3 day) | N | N | 260010554 | CISPLATIN + ETOPOSIDE + IFOSFAMIDE |
| 260009836 | 260012392 | 1.62 | 100.6 | Adjuvant (A) | 2016-10-11 | 2016-10-11 | EP | N | N | 260010561 | NOT MATCHED |
| 260009837 | 260006274 | 1.73 | 92.8 | Adjuvant (A) | 2013-02-28 | 2013-03-04 | Trial Unspecified | N | N | 260010563 | CISPLATIN + VINORELBINE |
| 260009838 | 260006274 | 1.75 | 86.5 | Palliative (P) | 2014-01-31 | 2014-02-04 | CISPLATIN + ETOPOSIDE | 02 | N | 260010563 | TIP |
| 260009839 | 260006274 | 1.64 | null | Palliative (P) | 2014-06-01 | 2014-06-02 | Carboplatin + Pemetrexed | 2 | N | 260010563 | FEC |
| 260009840 | 260006275 | 1.74 | 73 | Curative (C) | 2017-12-03 | 2017-12-03 | Rituximab | 2 | N | 260010612 | BENDAMUSTINE |